Ilex Medical (ILX.TA) Stock Price

Ilex Medical Price

TASE·CLOSED
5,172.00ILS+0.00 (+0.00 %)
Market closed

Over the last 19 years Ilex Medical grew revenue by 9.4% annually, reaching 920.37 M ILS. Earnings per share have grown at 4.6% per year over the last 19 years. For Ilex Medical, the net margin of 4.2% is down versus 12.7% a few years ago. At today's price the dividend yield works out to roughly 0.03%. The payout ratio is around 39% of earnings. The dividend has grown at 1.2% per year over the past 18 years. The stock trades about 12% above its 52-week low.

Ilex Medical stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Ilex Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Ilex Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Ilex Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Ilex Medical Stock Price History
DateIlex Medical Price
8/14/20265,172.00 ILS
8/13/20265,172.00 ILS
8/12/20265,172.00 ILS
8/11/20265,172.00 ILS
8/10/20265,057.00 ILS
8/7/20265,001.00 ILS
8/6/20264,967.00 ILS
8/5/20265,008.00 ILS
8/4/20265,004.00 ILS
7/31/20264,999.00 ILS
7/30/20264,938.00 ILS
7/29/20264,846.00 ILS
7/28/20264,945.00 ILS
7/27/20264,853.00 ILS
7/24/20264,950.00 ILS
7/22/20264,846.00 ILS
7/21/20264,841.00 ILS
7/20/20264,850.00 ILS
7/17/20264,939.00 ILS
7/16/20264,975.00 ILS
7/15/20264,927.00 ILS
7/14/20264,957.00 ILS
7/13/20264,973.00 ILS
7/10/20264,979.00 ILS
7/9/20264,981.00 ILS
7/8/20264,981.00 ILS
7/7/20264,981.00 ILS
7/6/20264,918.00 ILS
7/3/20264,902.00 ILS
7/2/20264,909.00 ILS
7/1/20264,910.00 ILS
6/30/20264,895.00 ILS
6/29/20264,900.00 ILS
6/26/20264,896.00 ILS
6/25/20264,788.00 ILS
6/24/20264,789.00 ILS
6/23/20264,807.00 ILS
6/22/20264,838.00 ILS
6/19/20264,835.00 ILS
6/18/20264,831.00 ILS
6/17/20264,834.00 ILS
6/16/20264,862.00 ILS
6/15/20265,048.00 ILS
6/12/20264,902.00 ILS
6/11/20264,884.00 ILS
6/10/20264,893.00 ILS
6/9/20264,893.00 ILS
6/8/20265,023.00 ILS
6/5/20264,993.00 ILS
6/4/20264,994.00 ILS
6/3/20265,071.00 ILS
6/2/20265,142.00 ILS
6/1/20265,111.00 ILS
5/29/20265,189.00 ILS
5/28/20265,072.00 ILS
5/27/20264,975.00 ILS
5/26/20264,821.00 ILS
5/25/20264,821.00 ILS
5/22/20264,753.00 ILS
5/21/20264,753.00 ILS
5/20/20264,753.00 ILS
5/19/20264,663.00 ILS
5/18/20264,707.00 ILS
5/15/20264,789.00 ILS
5/14/20264,629.00 ILS
5/13/20264,700.00 ILS
5/12/20264,948.00 ILS
5/11/20265,199.00 ILS
5/8/20265,432.00 ILS
5/7/20265,395.00 ILS
5/6/20265,739.00 ILS
5/5/20265,584.00 ILS
5/4/20265,569.00 ILS
5/1/20265,566.00 ILS
4/30/20265,509.00 ILS
4/29/20265,490.00 ILS
4/28/20265,529.00 ILS
4/27/20265,580.00 ILS
4/24/20265,613.00 ILS
4/23/20265,640.00 ILS
4/22/20265,648.00 ILS
4/21/20265,648.00 ILS
4/20/20265,648.00 ILS
4/17/20265,484.00 ILS
4/16/20265,430.00 ILS
4/15/20265,608.00 ILS
4/14/20265,633.00 ILS
4/13/20265,762.00 ILS
4/10/20265,775.00 ILS
4/9/20265,974.00 ILS
4/6/20266,012.00 ILS
4/3/20266,073.00 ILS
3/31/20266,122.00 ILS
3/30/20265,822.00 ILS
3/27/20265,782.00 ILS
3/26/20265,811.00 ILS
3/25/20265,875.00 ILS
3/24/20265,760.00 ILS
3/23/20265,757.00 ILS
3/20/20265,764.00 ILS
3/19/20266,136.00 ILS
3/18/20266,001.00 ILS
3/17/20266,079.00 ILS
3/16/20265,933.00 ILS
3/13/20266,000.00 ILS
3/12/20266,000.00 ILS
3/11/20266,150.00 ILS
3/10/20266,215.00 ILS
3/9/20266,050.00 ILS
3/6/20266,058.00 ILS
3/5/20265,955.00 ILS
3/4/20266,100.00 ILS
3/2/20265,942.00 ILS
2/27/20266,000.00 ILS
2/26/20265,887.00 ILS
2/25/20265,804.00 ILS
2/24/20265,799.00 ILS
2/23/20265,796.00 ILS
2/20/20265,796.00 ILS
2/19/20265,746.00 ILS
2/18/20265,702.00 ILS
2/17/20265,719.00 ILS
2/16/20265,692.00 ILS
2/13/20265,928.00 ILS
2/12/20265,970.00 ILS
2/11/20265,951.00 ILS
2/10/20266,080.00 ILS
2/9/20266,139.00 ILS
2/6/20266,109.00 ILS
2/5/20266,000.00 ILS
2/4/20266,409.00 ILS
2/3/20266,403.00 ILS
2/2/20266,216.00 ILS
1/30/20266,325.00 ILS
1/29/20266,344.00 ILS
1/28/20266,392.00 ILS
1/27/20266,594.00 ILS
1/26/20266,633.00 ILS
1/23/20266,606.00 ILS
1/22/20266,470.00 ILS
1/21/20266,453.00 ILS
1/20/20266,475.00 ILS
1/19/20266,550.00 ILS
1/16/20266,522.00 ILS
1/15/20266,891.00 ILS
1/14/20266,843.00 ILS
1/13/20266,566.00 ILS
1/12/20266,827.00 ILS
1/9/20266,968.00 ILS
1/8/20266,657.00 ILS
1/7/20266,590.00 ILS
1/6/20266,935.00 ILS
1/5/20266,698.00 ILS
1/1/20266,755.00 ILS
12/31/20256,650.00 ILS
12/30/20256,700.00 ILS
12/29/20256,610.00 ILS
12/28/20256,708.00 ILS
12/25/20256,724.00 ILS
12/24/20256,542.00 ILS
12/23/20256,808.00 ILS
12/22/20256,771.00 ILS
12/21/20256,600.00 ILS
12/18/20256,595.00 ILS
12/17/20256,410.00 ILS
12/16/20256,402.00 ILS
12/15/20256,322.00 ILS
12/14/20256,201.00 ILS
12/11/20256,250.00 ILS
12/10/20256,130.00 ILS
12/9/20256,200.00 ILS
12/8/20256,200.00 ILS
12/7/20256,130.00 ILS
12/4/20256,418.00 ILS
12/3/20256,467.00 ILS
12/2/20256,470.00 ILS
12/1/20256,324.00 ILS
11/30/20256,325.00 ILS
11/27/20256,379.00 ILS
11/26/20256,608.00 ILS
11/25/20256,629.00 ILS
11/24/20256,729.00 ILS
11/23/20256,799.00 ILS
11/20/20256,929.00 ILS
11/19/20257,080.00 ILS
11/18/20256,962.00 ILS
11/17/20256,950.00 ILS
11/16/20256,944.00 ILS
11/13/20256,960.00 ILS
11/12/20256,976.00 ILS
11/11/20256,894.00 ILS
11/10/20256,715.00 ILS
11/9/20256,714.00 ILS
11/6/20256,714.00 ILS
11/5/20256,621.00 ILS
11/4/20256,620.00 ILS
11/3/20256,666.00 ILS
11/2/20256,497.00 ILS
10/30/20256,526.00 ILS
10/29/20256,526.00 ILS
10/28/20256,520.00 ILS
10/27/20256,458.00 ILS
10/26/20256,452.00 ILS
10/23/20256,550.00 ILS
10/22/20256,526.00 ILS
10/21/20256,480.00 ILS
10/20/20256,533.00 ILS
10/19/20256,539.00 ILS
10/16/20256,502.00 ILS
10/15/20256,570.00 ILS
10/12/20256,476.00 ILS
10/9/20256,393.00 ILS
10/8/20256,352.00 ILS
10/5/20256,347.00 ILS
9/30/20256,670.00 ILS
9/29/20256,501.00 ILS
9/28/20256,580.00 ILS
9/25/20256,420.00 ILS
9/21/20256,305.00 ILS
9/18/20256,381.00 ILS
9/17/20256,183.00 ILS
9/16/20256,411.00 ILS
9/15/20256,439.00 ILS
9/14/20256,331.00 ILS
9/11/20256,370.00 ILS
9/10/20256,371.00 ILS
9/9/20256,147.00 ILS
9/8/20256,033.00 ILS
9/7/20256,033.00 ILS
9/4/20256,012.00 ILS
9/3/20256,058.00 ILS
9/2/20256,000.00 ILS
9/1/20256,028.00 ILS
8/31/20256,200.00 ILS
8/28/20256,230.00 ILS
8/27/20256,204.00 ILS
8/26/20256,124.00 ILS
8/25/20256,057.00 ILS
8/24/20256,146.00 ILS
8/21/20256,124.00 ILS
8/20/20256,053.00 ILS
8/19/20256,030.00 ILS
8/18/20256,046.00 ILS
Access this data via the Eulerpool API
Get Free API Key

Ilex Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
553.66 M ILS
53.38 M ILS
37.40 M ILS
Jan 1, 2018
601.13 M ILS
75.81 M ILS
46.98 M ILS
Jan 1, 2019
633.96 M ILS
82.87 M ILS
60.26 M ILS
Jan 1, 2020
946.45 M ILS
150.43 M ILS
120.62 M ILS
Jan 1, 2021
1.06 B ILS
257.14 M ILS
197.48 M ILS
Jan 1, 2022
872.54 M ILS
141.47 M ILS
102.12 M ILS
Jan 1, 2023
916.25 M ILS
82.40 M ILS
50.89 M ILS
Jan 1, 2024
920.37 M ILS
65.94 M ILS
38.98 M ILS

Ilex Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 17, 2026, 3:14 PM
 
REVENUEB ILS
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM ILS
EBITM ILS
EBIT MARGIN%
NET INCOMEM ILS
NET INCOME GROWTH%
DIV.ILS
DIV. GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
0.240.250.430.470.460.430.500.520.550.600.630.951.060.870.920.92
15.091.2374.099.53-2.12-6.2915.054.236.768.685.3249.4512.05-17.745.050.44
31.5631.5829.7728.4528.2028.2429.9826.8326.7630.7830.8128.9636.4233.1425.1123.70
77.0078.00128.00134.00130.00122.00149.00139.00148.00185.00195.00274.00386.00289.00230.00218.00
40.0036.0055.0038.0036.0042.0054.0049.0053.0075.0082.00150.00257.00141.0082.0065.00
16.3914.5712.798.077.819.7210.879.469.5812.4812.9515.8624.2516.178.957.07
30.0028.0032.00-22.00-22.0022.0031.0027.0037.0046.0060.00120.00197.00102.0050.0038.00
66.67-6.6714.29-168.75–-200.0040.91-12.9037.0424.3230.43100.0064.17-48.22-50.98-24.00
2.603.69–––3.68–3.995.98–2.49–5.325.321.921.36
246.6741.92––––––49.87–––––-63.91-29.17
10.0010.0010.0010.0010.0010.0410.0410.0410.0410.0410.0410.7311.2811.2811.1911.19
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Ilex Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Ilex Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Ilex Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Ilex Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Ilex Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Ilex Medical stock margins

The Ilex Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ilex Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ilex Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
26.86 %
9.64 %
6.76 %
Jan 1, 2018
30.87 %
12.61 %
7.82 %
Jan 1, 2019
30.85 %
13.07 %
9.50 %
Jan 1, 2020
28.98 %
15.89 %
12.74 %
Jan 1, 2021
36.40 %
24.24 %
18.61 %
Jan 1, 2022
33.14 %
16.21 %
11.70 %
Jan 1, 2023
25.17 %
8.99 %
5.55 %
Jan 1, 2024
23.75 %
7.16 %
4.24 %

Ilex Medical Stock Revenue, EBIT, Earnings per Share

The Ilex Medical earnings per share therefore indicates how much revenue Ilex Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
55.17 ILS
5.32 ILS
3.73 ILS
Jan 1, 2018
59.90 ILS
7.55 ILS
4.68 ILS
Jan 1, 2019
63.17 ILS
8.26 ILS
6.00 ILS
Jan 1, 2020
88.19 ILS
14.02 ILS
11.24 ILS
Jan 1, 2021
94.02 ILS
22.79 ILS
17.50 ILS
Jan 1, 2022
77.36 ILS
12.54 ILS
9.05 ILS
Jan 1, 2023
81.88 ILS
7.36 ILS
4.55 ILS
Jan 1, 2024
82.26 ILS
5.89 ILS
3.48 ILS

Ilex Medical business model & stock analysis

Ilex Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Ilex Medical historical P/E ratio, EBIT multiple, and P/S ratio

Ilex Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Ilex Medical shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
10.04 M Stocks
Jan 1, 2018
10.04 M Stocks
Jan 1, 2019
10.04 M Stocks
Jan 1, 2020
10.73 M Stocks
Jan 1, 2021
11.28 M Stocks
Jan 1, 2022
11.28 M Stocks
Jan 1, 2023
11.19 M Stocks
Jan 1, 2024
11.19 M Stocks

Ilex Medical Dividend History

17 years of dividend payments

YearAnnual DividendYoY ChangePayments
20251.22ILS↓ 10.6%1×
Apr 7, 20251.22ILS↓ 10.6%1/1
20241.36ILS↓ 28.8%1×
20231.92ILS↓ 64.0%1×
20225.32ILS↓ 0.0%1×
20215.32ILS↑ 113.5%1×
20192.49ILS↑ 38.9%1×
20181.79ILS↑ 20.0%1×
20171.49ILS↑ 50.0%1×
20161.00ILS↓ 45.9%1×
20141.84ILS↑ 2,114.8%2×

Ilex Medical dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
40.10 %
Jan 1, 2018
38.31 %
Jan 1, 2019
41.49 %
Jan 1, 2020
46.72 %
Jan 1, 2021
30.39 %
Jan 1, 2022
58.74 %
Jan 1, 2023
42.21 %
Jan 1, 2024
39.21 %
Price targets and forecasts for Ilex Medical are not yet available.

Ilex Medical shareholder structure

% Name
0.20067%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.05787%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.03045%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.00696%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

Ilex Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
85.3%
Float Shares
-
Shares Outstanding
-

Ilex Medical Executives and Management Board

12 members · avg. age 53 · 58 % women

CB

Mr. Claude Benshaul (55)

Chief Operating Officer · since 1993

631,000.00 ILS

Management

TG

Ms. Tamar Galili (43)

Chief Executive Officer · since 2006

352,000.00 ILS
HN

Ms. Hilla Nissim-Gabbay (34)

Vice President - Finance

–
IP

Ms. Iris Perelmuter (47)

Vice President of Sales and Marketing

–
ZD

Mr. Ziv Dahari (40)

Vice President - Business Development

–
AS

Ms. Andrea Sitt-Levy (43)

General Counsel, Secretary

–

Board of Directors

MB

Dr. Moshe Benshaul (76)

Director · since 1990

6.13 M ILS
NA

Mr. Netanel Aqua (30)

Finance Director

–
LB

Ms. Lucien Benshaul (80)

Director · since 1994

–
LA

Ms. Lily Ayalon (53)

External Director

–
HS

Ms. Hava Shechter (65)

Independent Director

–
RG

Dr. Roberto Nathanson Goldstrom (64)

External Independent Director

–

Frequently asked questions about Ilex Medical

Converted at the current exchange rate, the Ilex Medical share trades at 1,513.10 EUR (5,172.00 ILS).

No history available for Ilex Medical.

The revenue cannot currently be calculated for Ilex Medical.

The profit cannot currently be calculated for Ilex Medical.

The P/E ratio cannot be calculated for Ilex Medical at the moment.

The P/S cannot be calculated for Ilex Medical currently.

The Eulerpool Quality Score for Ilex Medical is 3/10.

The ISIN of Ilex Medical is IL0010807530. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ilex Medical is ILX.TA. The ticker symbol is used to trade Ilex Medical shares on the stock exchange.

Over the past 12 months, Ilex Medical paid a dividend of 1.36 ILS . This corresponds to a dividend yield of about 0.03 %. For the coming 12 months, Ilex Medical is expected to pay a dividend of 1.36 ILS.

The current dividend yield of Ilex Medical is 0.03 %.

Ilex Medical pays a dividend, distributed in the months of , , , .

Ilex Medical paid dividends every year for the past 5 years.

For the upcoming 12 months, dividends amounting to 1.36 ILS are expected. This corresponds to a dividend yield of 0.03 %.

Ilex Medical is assigned to the 'Health' sector.

To receive the latest dividend of Ilex Medical from amounting to 1.22 ILS, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Ilex Medical distributed 1.92 ILS as dividends.

The dividends of Ilex Medical are distributed in ILS.

All fundamentals and in-depth analysis of Ilex Medical

Our stock analysis for Ilex Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ilex Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Ilex Medical Stock
Ilex Medical Revenue→
Ilex Medical Stock
Ilex Medical Net Income→
Ilex Medical Stock
Ilex Medical P/E→
Ilex Medical Stock
Ilex Medical P/S→
Ilex Medical Stock
Ilex Medical EBIT→
Ilex Medical Stock
Ilex Medical Dividend→
Ilex Medical Stock
Ilex Medical Directors Dealings→
Ilex Medical Stock
Ilex Medical Stocks→
Ilex Medical Stock
Ilex Medical Market capitalization→
Ilex Medical Stock
Ilex Medical Debt→
Ilex Medical Stock
Ilex Medical Liabilities→
Ilex Medical Stock
Ilex Medical Equity→
Ilex Medical Stock
Ilex Medical AAQS→
Ilex Medical Stock
Ilex Medical Employees→
Ilex Medical Stock
Ilex Medical ROE→
Ilex Medical Stock
Ilex Medical ROA→
Ilex Medical Stock
Ilex Medical ROCE→
Ilex Medical Stock
Ilex Medical News→
Ilex Medical Stock
Ilex Medical Analyst Price Targets→

Health Stocks

IlluminaIldong Holdings CoIlsung IS CoIl Dong Pharmaceutical CoIlyang Pharmaceutical CoIkonisysIm CannabisIfa SystemsIMAC HoldingsIDT AustraliaImageOne CoIdorsiaAll Stocks A–Z →